Since 2014, the MONARCH, PALOMA, and MONALEESA studies have demonstrated that CDK4/6i is gradually changing the course of endocrine therapy for advanced BC [143,144,145,146,147,148,149]. This evidence concerns the gene CDK4 and breast cancer.